Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1441 to 1450 of 1535

TitleReference numberPublishedLast updated
Refractory extrapulmonary sarcoidosis: infliximabES4
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomibTA427
Smartinhaler for asthmaMIB90
TuberculosisQS141
Learning disability: identifying and managing mental health problemsQS142
Everolimus with exemestane for treating advanced breast cancer after endocrine therapyTA421
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA422
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimensTA423
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancerTA424
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemiaTA425

Results per page

  1. 10
  2. 25
  3. 50
  4. All